Is BSX Worth Buying in 2026?

Boston Scientific Corp.

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-07-26

Here’s whether Boston Scientific Corp. (BSX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 48 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.87% over 10 days); weak 1-year return of -58.3%; 3-month momentum negative (-28.7%). Currently 59.6% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

BSX is trading below its 200-day MA ($74.42) — a key warning sign the longer-term trend is under pressure. An RSI of 48.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -58.3% compares to +16.5% for SPY (trailed the market by 74.8%). The current 59.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,166 today
vs. S&P 500 (SPY) — same period trailed market by 74.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($74.42)
Above 50-day MA ($47.45)
RSI(14) neutral zone (30–70) — currently 48.0
Positive return (-58.3%)
!Within 10% of period high (−59.6%)
Period Range $44.25
$42.20 $109.50
RSI (14) 48.0
0 · OversoldOverbought · 100

Key Metrics

Price$44.25
Period Return-58.3%
Period High$109.50
Period Low$42.20
Drawdown−59.6%
MA-50$47.45
MA-200$74.42
RSI (14)48.0
Avg Volume (30d)19.2M
vs. SPYtrailed by 74.8%
Return Rank#880 of 999

Trade BSX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers